Precigen (PGEN) Provides Pipeline and Corporate Updates
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St ends higher as stocks reclaim some shine
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
Precigen Provides Pipeline and Corporate Updates at the 41st Annual J.P. Morgan Healthcare Conference
January 11, 2023 6:45 PM ESTÂ Company achieved significant progress for its clinical pipeline in 2022Â Â Precigen to host R&D Day virtual event on January 24, 2023, at 4:30 PM ET to share safety and efficacy data from the Phase 1 dose escalation and expansion cohorts of PRGN-2012 AdenoVerse immunotherapy in recurrent respiratory papillomatosis (RRP)
GERMANTOWN, Md., Jan. 11, 2023 /PRNewswire/ -- Precigen, Inc. (Nasdaq:... More
